{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:50:56Z","timestamp":1792219856015,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010289","name":"Princess Margaret Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtct.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T18:46:37Z","timestamp":1691865997000},"page":"697.e1-697.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-9323","authenticated-orcid":false,"given":"Mariana Pinto","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-4312","authenticated-orcid":false,"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0105-2086","authenticated-orcid":false,"given":"Armin","family":"Gerbitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Dong Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9251-3609","authenticated-orcid":false,"given":"Arjun Datt","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios V.","family":"Michelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Novitzky-Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7595-0113","authenticated-orcid":false,"given":"Ivan","family":"Pasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.08.009_bib0001","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2010-04-278317","article-title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","volume":"116","author":"Gupta","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0002","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0003","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.bbmt.2016.07.010","article-title":"Impact of donor type on outcome after allogeneic hematopoietic cell transplantation for acute leukemia","volume":"22","author":"Solomon","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0004","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbmt.2007.01.073","article-title":"Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia","volume":"13","author":"Moore","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0005","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0006","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0007","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/14653249.2012.681041","article-title":"Influence of related donor age on outcomes after peripheral blood stem cell transplantation","volume":"14","author":"Richa","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2023.08.009_bib0008","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.leukres.2015.05.003","article-title":"Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome","volume":"39","author":"Bastida","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.jtct.2023.08.009_bib0009","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0010","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2012-08-453860","article-title":"Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?","volume":"121","author":"Alousi","year":"2013","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.08.009_bib0011","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood-2022-162742","article-title":"Comparison of allogeneic hematopoietic cell transplantation outcomes from younger matched unrelated donor versus older sibling donor for acute myeloid leukemia","volume":"140","author":"Bilal Abid","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0012","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamaoncol.2021.6846","article-title":"Relapse and disease-free survival in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation using older matched sibling donors vs younger matched unrelated donors","volume":"8","author":"Guru Murthy","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0013","first-page":"1","article-title":"Contemporary approach to acute myeloid leukemia therapy in 2022","volume":"42","author":"Roloff","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jtct.2023.08.009_bib0014","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0015","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1182\/blood-2006-05-021907","article-title":"Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)","volume":"109","author":"Estey","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0016","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbmt.2011.06.005","article-title":"Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission","volume":"17","author":"Farag","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0017","doi-asserted-by":"crossref","first-page":"265.e1","DOI":"10.1016\/j.jtct.2022.02.001","article-title":"Improving safety and outcomes after allogeneic hematopoietic cell transplantation: a single-center experience","volume":"28","author":"Salas","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.009_bib0018","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbmt.2020.04.021","article-title":"Less is more: superior graft versus-host disease-free\/relapse-free survival with reduced intensity conditioning and dual t cell depletion in acute myelogenous leukemia","volume":"26","author":"Salas","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajh.23955","article-title":"Mycophenolate based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative related donor stem cell transplantation","volume":"90","author":"Hamad","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ejh.13321","article-title":"Reduced-intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia","volume":"103","author":"Salas","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0021","first-page":"105","article-title":"Safety and efficacy of haploidentical peripheral blood stem cell transplantation for myeloid malignancies using post-transplantation cyclophosphamide and anti-thymocyte globulin as graft versus host disease prophylaxis","volume":"1","author":"Salas","year":"2019","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.jtct.2023.08.009_bib0022","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41409-020-0813-9","article-title":"Dual T-cell depletion with ATG and PTCy for peripheral blood reduced-intensity conditioning allo-HSCT results in very low rates of GVHD","volume":"55","author":"Salas","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0023","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbmt.2017.02.022","article-title":"Current graft-versus-host disease\u2013free, relapse-free survival: a dynamic endpoint to better define efficacy after allogenic transplant","volume":"23","author":"Solomon","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0024","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.08.009_bib0025","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1182\/blood-2022-163517","article-title":"Younger matched unrelated donors confer a decreased relapse risk as compared to older sibling donors for adult B-cell ALL patients undergoing allogeneic hematopoietic cell transplantation","volume":"140","author":"Bilal Abid","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.009_bib0026","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbmt.2014.09.021","article-title":"Impact of donor age on outcome after allogeneic hematopoietic cell transplantation","volume":"21","author":"Rezvani","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0027","doi-asserted-by":"crossref","first-page":"50.e1","DOI":"10.1016\/j.jtct.2021.10.008","article-title":"Bloodstream infections and outcomes following allogeneic hematopoietic cell transplantation: a single-center study","volume":"28","author":"Carreira","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.009_bib0028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000507536","article-title":"Post-transplant cyclophosphamide combined with anti-thymocyte globulin as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplantation in high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"144","author":"Alanazi","year":"2021","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0029","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.26033","article-title":"Fresh vs. frozen allogeneic peripheral blood stem cell grafts: a successful timely option","volume":"96","author":"Alotaibi","year":"2021","journal-title":"Am Hematol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ejh.13714","article-title":"Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts","volume":"108","author":"Novitzky-Basso","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0031","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41409-023-01997-3","article-title":"Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?","volume":"58","author":"Konuma","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.009_bib0032","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/leu.2012.210","article-title":"Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings","volume":"27","author":"Kr\u00f6ger","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.08.009_bib0033","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.3390\/curroncol29080470","article-title":"Donor age and non-relapse mortality: study of their association after HLA-matched allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome","volume":"29","author":"Kadri","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jtct.2023.08.009_bib0034","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:19Z","timestamp":1763003419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723014665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666636723014665"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.009","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}